Showing results (301-310 of 498) with videos related to

Sort By:
Pageof 50
Vaccine|October 6, 2005
Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccinationEzra J Barzilay, Katherine L O'Brien, Yeong S Kwok, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumoniaJennifer D Loo, Laura Conklin, Katherine E Fleming-Dutra, et al.
Viruses|February 2, 2021
Investigating the Diversity and Host Range of Novel Parvoviruses from North American Ducks Using Epidemiology, Phylogenetics, Genome Structure, and Codon Usage AnalysisMarta Canuti, Joost T P Verhoeven, Hannah J Munro, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriageKatherine E Fleming-Dutra, Laura Conklin, Jennifer D Loo, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonizationJennifer D Loo, Laura Conklin, Katherine E Fleming-Dutra, et al.
Developmental Medicine and Child Neurology|May 11, 2020
Effect of pain on mood affective disorders in adults with cerebral palsyDaniel G Whitney, Sarah Bell, Daniel Whibley, et al.
PLOS Global Public Health|November 1, 2023
Knowledge of COVID-19 symptoms, transmission, and prevention: Evidence from health and demographic surveillance in Southern MozambiqueAriel Nhacolo, Zachary J Madewell, Jonathan A Muir, et al.
Cornea|May 8, 2009
Clinical features, outcomes, and costs of a conjunctivitis outbreak caused by the ST448 strain of Streptococcus pneumoniaeMichael E Zegans, Paul A Sanchez, Donald S Likosky, et al.
Vaccine|May 21, 2013
Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008Anne von Gottberg, Cheryl Cohen, Linda de Gouveia, et al.
Biomaterials|May 26, 2017
PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responsesToshiki Sekiya, Junya Yamagishi, John Henry V Gray, et al.
Pageof 50